drugset / Trial / NCT05890664
Colchicine After Electrocardioversion for Atrial Fibrillation
Phase 3
Recruiting
416 enrolled
University Hospital, Basel, Switzerland
Fondation Machaon, Switzerland, Genf · collabFoundation for Cardiovascular Research Basel · collabSwiss Heart Foundation · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate whether a 3 month treatment course of low-dose Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion (ECV) in patients with AF.
Timeline
- Start
- 2024-04-14
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | Oral |